Chiral Active β-Glucan Nanoparticles for Synergistic Delivery of Doxorubicin and Immune Potentiation

Chiral Active β-Glucan Nanoparticles for Synergistic Delivery of Doxorubicin and Immune Potentiation

Jintao Huang,1,* Chaoxi Wu,2,* Shunqing Tang,3 Pengjun Zhou,2 Jianping Deng,1 Zhen Zhang,1 Yifei Wang,2 Zhiping Wang1 1Guangdong Provincial Engineering Center of Topical Precise Drug Delivery System, School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510632, People’s Republ...

Full description

Bibliographic Details
Main Authors:	Huang J, Wu C, Tang S, Zhou P, Deng J, Zhang Z, Wang Y, Wang Z
Format:	Article
Language:	English
Published:	Dove Medical Press 2020-07-01
Series:	International Journal of Nanomedicine
Subjects:	-glucan chiral nanoparticles doxorubicin anti-cancer drug delivery systems immune-potentiation
Online Access:	https://www.dovepress.com/chiral-active-beta-glucan-nanoparticles-for-synergistic-delivery-of-do-peer-reviewed-article-IJN

Similar Items

Design and Synthesis of Doxorubicin Conjugated Gold Nanoparticles as Anticancer Drug Delivery System
by: Xia, Long
Published: (2017)

Dual Drug Delivery of Sorafenib and Doxorubicin from PLGA and PEG-PLGA Polymeric Nanoparticles
by: György Babos, et al.
Published: (2018-08-01)

Novel functionalized nanoparticles for tumor-targeting co-delivery of doxorubicin and siRNA to enhance cancer therapy
by: Xia Y, et al.
Published: (2017-12-01)

Transferrin-Conjugated Polymeric Nanoparticle for Receptor-Mediated Delivery of Doxorubicin in Doxorubicin-Resistant Breast Cancer Cells
by: Zar Chi Soe, et al.
Published: (2019-02-01)

Functionalized Mesoporous Silica Nanoparticles as Delivery Systems for Doxorubicin: Drug Loading and Release
by: Candace M. Day, et al.
Published: (2021-06-01)

Ratio of Drug/carrier as Dominant Factor in Determining Size of Doxorubicin-Loaded Beta-1,3- Glucan Nanoparticles: An Artificial Neural Networks Study
by: Zahra Nasrollahi, et al.
Published: (2020-04-01)

Enhanced tumor delivery and antitumor response of doxorubicin loaded albumin nanoparticles formulated based on a Schiff base
by: Li F, et al.
Published: (2016-08-01)

Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy
by: Tahir N, et al.
Published: (2019-07-01)

Codelivery of thioridazine and doxorubicin using nanoparticles for effective breast cancer therapy
by: Jin X, et al.
Published: (2016-09-01)

Doxorubicin and Edelfosine Combo-Loaded Lipid–Polymer Hybrid Nanoparticles for Synergistic Anticancer Effect Against Drug-Resistant Osteosarcoma
by: Yang P, et al.
Published: (2020-08-01)

Enlarged Pore Size Chiral Mesoporous Silica Nanoparticles Loaded Poorly Water-Soluble Drug Perform Superior Delivery Effect
by: Yingyu Guo, et al.
Published: (2019-09-01)

Beta-glucan complexes with selected nutraceuticals: Synthesis, characterization, and stability
by: Miroslav Veverka, et al.
Published: (2014-05-01)

Glucan Particle Encapsulated Rifampicin for Targeted Delivery to Macrophages
by: Gary Ostroff, et al.
Published: (2010-12-01)

Doxorubicin–Gelatin/Fe<sub>3</sub>O<sub>4</sub>–Alginate Dual-Layer Magnetic Nanoparticles as Targeted Anticancer Drug Delivery Vehicles
by: Chiung-Hua Huang, et al.
Published: (2020-08-01)

RBC-derived vesicles as a systemic delivery system of doxorubicin for lysosomal-mitochondrial axis-improved cancer therapy
by: Shu-Hui Wu, et al.
Published: (2021-05-01)

Hypoxia-Responsive Mesoporous Nanoparticles for Doxorubicin Delivery
by: Shakera Khatoon, et al.
Published: (2018-04-01)

Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [14C]-doxorubicin
by: Masarudin MJ, et al.
Published: (2015-12-01)

Preparation and characterization of TiO2-PEG NPs loaded doxorubicin
by: Zahra Sobhani, et al.
Published: (2019-06-01)

Duality of β-glucan microparticles: antigen carrier and immunostimulants
by: Baert K, et al.
Published: (2016-05-01)

Detection of Beta-Glucan Contamination in Nanotechnology-Based Formulations
by: Barry W. Neun, et al.
Published: (2020-07-01)

Self-assembled polymeric nanocarrier-mediated co-delivery of metformin and doxorubicin for melanoma therapy
by: Mingming Song, et al.
Published: (2021-01-01)

Optimizing Tumor Microenvironment for Cancer Immunotherapy: β-Glucan-Based Nanoparticles
by: Mei Zhang, et al.
Published: (2018-02-01)

Quercetin and doxorubicin co-delivery using mesoporous silica nanoparticles enhance the efficacy of gastric carcinoma chemotherapy
by: Fang J, et al.
Published: (2018-09-01)

Small Peptide-Doxorubicin Co-Assembly for Synergistic Cancer Therapy
by: Shuangfei Li, et al.
Published: (2020-01-01)

Enhanced Intestinal Permeation of Doxorubicin Using Chitosan Nanoparticles
by: Marziyeh Zare, et al.
Published: (2018-08-01)

Resveratrol solid lipid nanoparticles to trigger credible inhibition of doxorubicin cardiotoxicity
by: Zhang L, et al.
Published: (2019-07-01)

Albumin-Albumin/Lactosylated Core-Shell Nanoparticles: Therapy to Treat Hepatocellular Carcinoma for Controlled Delivery of Doxorubicin
by: Nayelli Guadalupe Teran-Saavedra, et al.
Published: (2020-11-01)

Combination Therapy with Doxorubicin-Loaded Reduced Albumin Nanoparticles and Focused Ultrasound in Mouse Breast Cancer Xenografts
by: Daehyun Kim, et al.
Published: (2020-09-01)

Self-Assembling β-Glucan Nanomedicine for the Delivery of siRNA
by: Kyungwoo Lee, et al.
Published: (2020-11-01)

CD20 monoclonal antibody targeted nanoscale drug delivery system for doxorubicin chemotherapy: an in vitro study of cell lysis of CD20-positive Raji cells
by: Jiang S, et al.
Published: (2016-11-01)

Intracellular Delivery of Doxorubicin by Iron Oxide-Based Nano-Constructs Increases Clonogenic Inactivation of Ionizing Radiation in HeLa Cells
by: Roxana Cristina Popescu, et al.
Published: (2021-06-01)

Sterically Stabilised Polymeric Mesoporous Silica Nanoparticles Improve Doxorubicin Efficiency: Tailored Cancer Therapy
by: Thashini Moodley, et al.
Published: (2020-02-01)

Biphenyl Wrinkled Mesoporous Silica Nanoparticles for pH-Responsive Doxorubicin Drug Delivery
by: Jason Lin, et al.
Published: (2020-04-01)

Application of a lipid-coated hollow calcium phosphate nanoparticle in synergistic co-delivery of doxorubicin and paclitaxel for the treatment of human lung cancer A549 cells
by: Wu C, et al.
Published: (2017-10-01)

Doxorubicin Loaded Magnesium Oxide Nanoflakes as pH Dependent Carriers for Simultaneous Treatment of Cancer and Hypomagnesemia
by: Tharindu A. Ranathunge, et al.
Published: (2019-02-01)

Chitosan, Polyethylene Glycol and Polyvinyl Alcohol Modified MgFe<sub>2</sub>O<sub>4</sub> Ferrite Magnetic Nanoparticles in Doxorubicin Delivery: A Comparative Study In Vitro
by: Deevak Ramnandan, et al.
Published: (2021-06-01)

Docetaxel and Doxorubicin Codelivery by Nanocarriers for Synergistic Treatment of Prostate Cancer
by: Ke Li, et al.
Published: (2019-12-01)

Sericin-Montmorillonite Composite Nanoparticles as Drug Delivery System in Human Liver Cancer: Development, Drug Release, Cellular Uptake and Cytotoxicity
by: Oznur AKBAL
Published: (2020-04-01)

Particulate and solubilized β-glucan and non-β-glucan fractions of Euglena gracilis induce pro- and anti-inflammatory innate immune cell responses and exhibit antioxidant properties
by: Phillips FC, et al.
Published: (2019-03-01)

Synthesis and cytotoxicity evaluation of electrospun PVA magnetic nanofibers containing doxorubicin as targeted nanocarrier for drug delivery
by: Tayebeh Shamspur, et al.
Published: (2017-12-01)